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aged 60.2±8.0 in average. Mortality was obtained from routine statistics and
median follow-up was 7.2 years. The association of adiponectin with mortality
was determined by a cox proportional hazard model. 
Results: Adiponectin (mean: 5.6±4.3 microg/mL) was significantly associ-
ated (p=0.001) with RHR (mean: 63.8±11.9 beats/mn) and LVEF (median:
55%, p=0.001) but not with the severity of coronary lesions (Gensini and
Jeopardy scores). After multivariable adjustment for age, tobacco consump-
tion, physical activity, history of diabetes, hypertension and dyslipidaemia,
waist girth, ApoA1, length of CHD and severity scores, adiponectin remained
significantly associated with mortality HR: 1.05 (1.01-1.09), p=0.008. In
people with RHR 61.5 beat/mn and LVEF <40% HRs increased significantly
from 2.70 (0.93-7.84) when adiponectin was below median (4.4 microg/mL)
to 7.29 (3.60-14.7) when it was above. The increased risk was similar when
RHR was below 61.5 microg/mL and LVEF below 40%, (from 2.66 (0.73-
9.77) to 6.80 (2.48-18.6)) or in men with RHR 61.5 microg/mL and LVEF
40%, although the strength of the relationship was smaller (from 1.22 (0.59-
2.51) to 2.79 (1.43-5.41)).
Conclusion: High adiponectin levels were associated with long term mor-
tality in French men suffering from CHD after multivariable adjustment. This
prognostic value remains significant whatever the severity of CHD.
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Background: Patients with psoriasis would be exposed to a high risk of
atherosclerosis. This study aimed to assess ten-year cardiovascular risk for
coronary heart disease in Tunisian psoriatic patients and to test the role of pso-
riasis severity and duration on cardiovascular risk.
Methods: A case-control study included 202 psoriatic patients and
216 healthy controls. Risk of coronary heart disease was estimated using the
Framingham risk score algorithm.
Results: Psoriatic patients had higher ten-year Framingham risk score
(12.71±3.81 vs. 7.45±6.66; p<0.001) than controls. Besides, a high risk score
(20% to 40%) was more frequent in psoriatic patients compared with controls
(18.3% vs. 6.5%; p<0.001) and a very high risk (>40%) was noted in 5.9% of
psoriatic patients versus 0% in controls. The cardiovascular risk tend to
increase with severity of psoriasis (10.05±11.22, 14.32±13.97 and
15.46±16.26 for low, high and very high risk levels, respectively). But, no
relationship wad found with duration of psoriasis.
Conclusion: Tunisian psoriatic patients have significantly greater risk of
developing coronary heart disease than controls. The more severe is the pso-
riasis; the higher the risk. Patients with psoriasis should be closely followed
for cardiovascular disease and preventive measures specific interventions
should be initiated according to guidelines in psoriatic patients
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Purpose: Elevated resting heart rate (HR) during the hospitalization for
acute myocardial infarction (MI) is an independent predictor of mortality.
However, there is no study that ascertained HR at early follow-up visit after
the introduction of beta blockers (BB), during the first year after MI. Thus,
our aim was to evaluate the prognostic impact of resting HR at early follow-
up visit after MI in first year survivors, independently of BB use.
Methods: In an MI incident cohort (1983-2007), resting HR at early
follow-up (range 1 to 12 months) after MI was retrieved from an ECG data-
base. First year survivor patients were followed from MI until death or last
follow-up. The patient’s population was divided into 5 categories according to
the HR level. Proportional hazards regression examined the association of HR
with mortality after adjustment for confounders, particularly BB.
Results: The mean follow-up of the 1587 included MI patients in sinus
rhythm (mean age 65±14 years, 62% men) was 9 years with 627 deaths.
Patients with elevated HR had a worse baseline risk profile. Elevated HR at
early follow-up was associated with an increased risk of death (table). In
patients taking or not BB, similar results were obtained (table).
Conclusion: Elevated resting HR at early follow-up visit after MI identi-
fies patients at increased risk of death, independently of BB use. This knowl-
edge may help physicians to identify high-risk subjects easily.
Resting HR at early follow-up (in BPM) in First Year Survivors after MI and 
Death (Adjusted Hazard Ratio (95% CI))*
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Aims: Recommendations of the African Type 2 Diabetes Practice Guide-
line for the use of electrocardiogram in the monitoring of people with diabetes
are non-specific. We assessed the prevalence and determinants of electrocar-
diographic abnormalities in people with diabetes in two referral centers in
Cameroon.
Methods: A total of 420 patients with type 2 diabetes (49% men) receiving
chronic care at the Douala General and Yaounde Central hospitals were
included. Electrocardiographic abnormalities were investigated and related to
potential history, clinical and biological determinants with the use of logistic
regression models.
Results: The mean age and median duration of diagnosed diabetes were
56.7 years and 4 years respectively. The main (prevalence – %) electrocardio-
graphic abnormities were: T waves alterations (20.9%), left ventricular hyper-
trophy according to the Cornell product criteria (16.4%), arrhythmia (16.2%),
ischemic heart disease (13.6%), conduction defects (11.9%), QTc prolongation
(10.2%) and ectopic beats (4.8%). Blood pressure variables (systolic, diastolic
and pulse pressure) were consistently associated with all abnormalities. Dia-
betes specific factors were associated to some, but not all abnormalities.
All 
(n=1587)
BB 
at hospital discharge
(n=1131)
No BB 
at hospital discharge 
(n=456)
HR60 1 1 1
60<HR70 1.5 (1.2-1.9) 1.5 (1.1-2.0) 1.5 (1.0-2.3)
70<HR80 1.6 (1.3-2.1) 1.4 (1.0-1.9) 1.9 (1.2-2.8)
80<HR80 2.1 (1.6-2.7) 1.8 (1.3-2.7) 2.2 (1.4-3.5)
HR>90 2.2 (1.7-2.9) 1.9 (1.3-2.9) 2.5 (1.6-3.9)
*Adjusted for age, sex, body mass index, smoking status, hyperlipidemia, 
hypertension, heart failure, reperfusion/revascularization procedures, 
comorbidity as measured by the Charlson index. Adjustment also for BB at 
discharge in All population.
